【市場調査レポート】経口用新型コロナウイルス感染症治療剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Oral COVID-19 Drug Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。経口用新型コロナウイルス感染症治療剤のグローバル市場インサイト・予測（～2028年） / Global Oral COVID-19 Drug Market Insights, Forecast to 2028 / QY2207E10438資料のイメージです。

• レポートコード：QY2207E10438
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、72ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の経口用新型コロナウイルス感染症治療剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口用新型コロナウイルス感染症治療剤の世界市場のxxx％を占める「錠剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の経口用新型コロナウイルス感染症治療剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの経口用新型コロナウイルス感染症治療剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの経口用新型コロナウイルス感染症治療剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

経口用新型コロナウイルス感染症治療剤のグローバル主要メーカーには、Pfizer、MSD and Ridgeback、Shionogiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

経口用新型コロナウイルス感染症治療剤市場は、種類と用途によって区分されます。世界の経口用新型コロナウイルス感染症治療剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
錠剤、カプセル

【用途別セグメント】
病院、クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 経口用新型コロナウイルス感染症治療剤製品概要
- 種類別市場（錠剤、カプセル）
- 用途別市場（病院、クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界の経口用新型コロナウイルス感染症治療剤販売量予測2017-2028
- 世界の経口用新型コロナウイルス感染症治療剤売上予測2017-2028
- 経口用新型コロナウイルス感染症治療剤の地域別販売量
- 経口用新型コロナウイルス感染症治療剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別経口用新型コロナウイルス感染症治療剤販売量
- 主要メーカー別経口用新型コロナウイルス感染症治療剤売上
- 主要メーカー別経口用新型コロナウイルス感染症治療剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（錠剤、カプセル）
- 経口用新型コロナウイルス感染症治療剤の種類別販売量
- 経口用新型コロナウイルス感染症治療剤の種類別売上
- 経口用新型コロナウイルス感染症治療剤の種類別価格
・用途別市場規模（病院、クリニック）
- 経口用新型コロナウイルス感染症治療剤の用途別販売量
- 経口用新型コロナウイルス感染症治療剤の用途別売上
- 経口用新型コロナウイルス感染症治療剤の用途別価格
・北米市場
- 北米の経口用新型コロナウイルス感染症治療剤市場規模（種類別、用途別）
- 主要国別の経口用新型コロナウイルス感染症治療剤市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの経口用新型コロナウイルス感染症治療剤市場規模（種類別、用途別）
- 主要国別の経口用新型コロナウイルス感染症治療剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の経口用新型コロナウイルス感染症治療剤市場規模（種類別、用途別）
- 主要国別の経口用新型コロナウイルス感染症治療剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の経口用新型コロナウイルス感染症治療剤市場規模（種類別、用途別）
- 主要国別の経口用新型コロナウイルス感染症治療剤市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの経口用新型コロナウイルス感染症治療剤市場規模（種類別、用途別）
- 主要国別の経口用新型コロナウイルス感染症治療剤市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、MSD and Ridgeback、Shionogi
・産業チェーン及び販売チャネル分析
- 経口用新型コロナウイルス感染症治療剤の産業チェーン分析
- 経口用新型コロナウイルス感染症治療剤の原材料
- 経口用新型コロナウイルス感染症治療剤の生産プロセス
- 経口用新型コロナウイルス感染症治療剤の販売及びマーケティング
- 経口用新型コロナウイルス感染症治療剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 経口用新型コロナウイルス感染症治療剤の産業動向
- 経口用新型コロナウイルス感染症治療剤のマーケットドライバー
- 経口用新型コロナウイルス感染症治療剤の課題
- 経口用新型コロナウイルス感染症治療剤の阻害要因
・主な調査結果

Market Analysis and Insights: Global Oral COVID-19 Drug Market
Due to the COVID-19 pandemic, the global Oral COVID-19 Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Tablet accounting for % of the Oral COVID-19 Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Oral COVID-19 Drug market size is valued at US$ million in 2021, while the US and Europe Oral COVID-19 Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral COVID-19 Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Oral COVID-19 Drug include Pfizer, MSD and Ridgeback and Shionogi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oral COVID-19 Drug Scope and Segment
Oral COVID-19 Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral COVID-19 Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinics
By Company
Pfizer
MSD and Ridgeback
Shionogi
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Oral COVID-19 Drug Product Introduction
1.2 Market by Type
1.2.1 Global Oral COVID-19 Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Oral COVID-19 Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral COVID-19 Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Oral COVID-19 Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral COVID-19 Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral COVID-19 Drug Sales by Region
2.4.1 Global Oral COVID-19 Drug Sales by Region (2017-2022)
2.4.2 Global Sales Oral COVID-19 Drug by Region (2023-2028)
2.5 Global Oral COVID-19 Drug Revenue by Region
2.5.1 Global Oral COVID-19 Drug Revenue by Region (2017-2022)
2.5.2 Global Oral COVID-19 Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral COVID-19 Drug Sales by Manufacturers
3.1.1 Global Top Oral COVID-19 Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Oral COVID-19 Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral COVID-19 Drug in 2021
3.2 Global Oral COVID-19 Drug Revenue by Manufacturers
3.2.1 Global Oral COVID-19 Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral COVID-19 Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral COVID-19 Drug Revenue in 2021
3.3 Global Oral COVID-19 Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral COVID-19 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral COVID-19 Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral COVID-19 Drug Sales by Type
4.1.1 Global Oral COVID-19 Drug Historical Sales by Type (2017-2022)
4.1.2 Global Oral COVID-19 Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral COVID-19 Drug Sales Market Share by Type (2017-2028)
4.2 Global Oral COVID-19 Drug Revenue by Type
4.2.1 Global Oral COVID-19 Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Oral COVID-19 Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral COVID-19 Drug Revenue Market Share by Type (2017-2028)
4.3 Global Oral COVID-19 Drug Price by Type
4.3.1 Global Oral COVID-19 Drug Price by Type (2017-2022)
4.3.2 Global Oral COVID-19 Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral COVID-19 Drug Sales by Application
5.1.1 Global Oral COVID-19 Drug Historical Sales by Application (2017-2022)
5.1.2 Global Oral COVID-19 Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral COVID-19 Drug Sales Market Share by Application (2017-2028)
5.2 Global Oral COVID-19 Drug Revenue by Application
5.2.1 Global Oral COVID-19 Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Oral COVID-19 Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral COVID-19 Drug Revenue Market Share by Application (2017-2028)
5.3 Global Oral COVID-19 Drug Price by Application
5.3.1 Global Oral COVID-19 Drug Price by Application (2017-2022)
5.3.2 Global Oral COVID-19 Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral COVID-19 Drug Market Size by Type
6.1.1 North America Oral COVID-19 Drug Sales by Type (2017-2028)
6.1.2 North America Oral COVID-19 Drug Revenue by Type (2017-2028)
6.2 North America Oral COVID-19 Drug Market Size by Application
6.2.1 North America Oral COVID-19 Drug Sales by Application (2017-2028)
6.2.2 North America Oral COVID-19 Drug Revenue by Application (2017-2028)
6.3 North America Oral COVID-19 Drug Market Size by Country
6.3.1 North America Oral COVID-19 Drug Sales by Country (2017-2028)
6.3.2 North America Oral COVID-19 Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oral COVID-19 Drug Market Size by Type
7.1.1 Europe Oral COVID-19 Drug Sales by Type (2017-2028)
7.1.2 Europe Oral COVID-19 Drug Revenue by Type (2017-2028)
7.2 Europe Oral COVID-19 Drug Market Size by Application
7.2.1 Europe Oral COVID-19 Drug Sales by Application (2017-2028)
7.2.2 Europe Oral COVID-19 Drug Revenue by Application (2017-2028)
7.3 Europe Oral COVID-19 Drug Market Size by Country
7.3.1 Europe Oral COVID-19 Drug Sales by Country (2017-2028)
7.3.2 Europe Oral COVID-19 Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral COVID-19 Drug Market Size by Type
8.1.1 Asia Pacific Oral COVID-19 Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral COVID-19 Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Oral COVID-19 Drug Market Size by Application
8.2.1 Asia Pacific Oral COVID-19 Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral COVID-19 Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Oral COVID-19 Drug Market Size by Region
8.3.1 Asia Pacific Oral COVID-19 Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral COVID-19 Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oral COVID-19 Drug Market Size by Type
9.1.1 Latin America Oral COVID-19 Drug Sales by Type (2017-2028)
9.1.2 Latin America Oral COVID-19 Drug Revenue by Type (2017-2028)
9.2 Latin America Oral COVID-19 Drug Market Size by Application
9.2.1 Latin America Oral COVID-19 Drug Sales by Application (2017-2028)
9.2.2 Latin America Oral COVID-19 Drug Revenue by Application (2017-2028)
9.3 Latin America Oral COVID-19 Drug Market Size by Country
9.3.1 Latin America Oral COVID-19 Drug Sales by Country (2017-2028)
9.3.2 Latin America Oral COVID-19 Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral COVID-19 Drug Market Size by Type
10.1.1 Middle East and Africa Oral COVID-19 Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral COVID-19 Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral COVID-19 Drug Market Size by Application
10.2.1 Middle East and Africa Oral COVID-19 Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral COVID-19 Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral COVID-19 Drug Market Size by Country
10.3.1 Middle East and Africa Oral COVID-19 Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral COVID-19 Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Oral COVID-19 Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Oral COVID-19 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 MSD and Ridgeback
11.2.1 MSD and Ridgeback Corporation Information
11.2.2 MSD and Ridgeback Overview
11.2.3 MSD and Ridgeback Oral COVID-19 Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 MSD and Ridgeback Oral COVID-19 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MSD and Ridgeback Recent Developments
11.3 Shionogi
11.3.1 Shionogi Corporation Information
11.3.2 Shionogi Overview
11.3.3 Shionogi Oral COVID-19 Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Shionogi Oral COVID-19 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shionogi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral COVID-19 Drug Industry Chain Analysis
12.2 Oral COVID-19 Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral COVID-19 Drug Production Mode & Process
12.4 Oral COVID-19 Drug Sales and Marketing
12.4.1 Oral COVID-19 Drug Sales Channels
12.4.2 Oral COVID-19 Drug Distributors
12.5 Oral COVID-19 Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral COVID-19 Drug Industry Trends
13.2 Oral COVID-19 Drug Market Drivers
13.3 Oral COVID-19 Drug Market Challenges
13.4 Oral COVID-19 Drug Market Restraints
14 Key Findings in The Global Oral COVID-19 Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Oral COVID-19 Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Global Oral COVID-19 Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Oral COVID-19 Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oral COVID-19 Drug Sales by Region (2017-2022) & (K Units)
Table 7. Global Oral COVID-19 Drug Sales Market Share by Region (2017-2022)
Table 8. Global Oral COVID-19 Drug Sales by Region (2023-2028) & (K Units)
Table 9. Global Oral COVID-19 Drug Sales Market Share by Region (2023-2028)
Table 10. Global Oral COVID-19 Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oral COVID-19 Drug Revenue Market Share by Region (2017-2022)
Table 12. Global Oral COVID-19 Drug Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Oral COVID-19 Drug Revenue Market Share by Region (2023-2028)
Table 14. Global Oral COVID-19 Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Oral COVID-19 Drug Sales Share by Manufacturers (2017-2022)
Table 16. Global Oral COVID-19 Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Oral COVID-19 Drug Revenue Share by Manufacturers (2017-2022)
Table 18. Oral COVID-19 Drug Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Oral COVID-19 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Oral COVID-19 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral COVID-19 Drug as of 2021)
Table 21. Oral COVID-19 Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oral COVID-19 Drug Product Offered
Table 23. Date of Manufacturers Enter into Oral COVID-19 Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral COVID-19 Drug Sales by Type (2017-2022) & (K Units)
Table 26. Global Oral COVID-19 Drug Sales by Type (2023-2028) & (K Units)
Table 27. Global Oral COVID-19 Drug Sales Share by Type (2017-2022)
Table 28. Global Oral COVID-19 Drug Sales Share by Type (2023-2028)
Table 29. Global Oral COVID-19 Drug Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Oral COVID-19 Drug Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Oral COVID-19 Drug Revenue Share by Type (2017-2022)
Table 32. Global Oral COVID-19 Drug Revenue Share by Type (2023-2028)
Table 33. Oral COVID-19 Drug Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Oral COVID-19 Drug Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Oral COVID-19 Drug Sales by Application (2017-2022) & (K Units)
Table 36. Global Oral COVID-19 Drug Sales by Application (2023-2028) & (K Units)
Table 37. Global Oral COVID-19 Drug Sales Share by Application (2017-2022)
Table 38. Global Oral COVID-19 Drug Sales Share by Application (2023-2028)
Table 39. Global Oral COVID-19 Drug Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Oral COVID-19 Drug Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Oral COVID-19 Drug Revenue Share by Application (2017-2022)
Table 42. Global Oral COVID-19 Drug Revenue Share by Application (2023-2028)
Table 43. Oral COVID-19 Drug Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Oral COVID-19 Drug Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Oral COVID-19 Drug Sales by Type (2017-2022) & (K Units)
Table 46. North America Oral COVID-19 Drug Sales by Type (2023-2028) & (K Units)
Table 47. North America Oral COVID-19 Drug Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Oral COVID-19 Drug Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Oral COVID-19 Drug Sales by Application (2017-2022) & (K Units)
Table 50. North America Oral COVID-19 Drug Sales by Application (2023-2028) & (K Units)
Table 51. North America Oral COVID-19 Drug Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Oral COVID-19 Drug Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units)
Table 54. North America Oral COVID-19 Drug Sales by Country (2023-2028) & (K Units)
Table 55. North America Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Oral COVID-19 Drug Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Oral COVID-19 Drug Sales by Type (2017-2022) & (K Units)
Table 58. Europe Oral COVID-19 Drug Sales by Type (2023-2028) & (K Units)
Table 59. Europe Oral COVID-19 Drug Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Oral COVID-19 Drug Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Oral COVID-19 Drug Sales by Application (2017-2022) & (K Units)
Table 62. Europe Oral COVID-19 Drug Sales by Application (2023-2028) & (K Units)
Table 63. Europe Oral COVID-19 Drug Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Oral COVID-19 Drug Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units)
Table 66. Europe Oral COVID-19 Drug Sales by Country (2023-2028) & (K Units)
Table 67. Europe Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Oral COVID-19 Drug Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Oral COVID-19 Drug Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Oral COVID-19 Drug Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Oral COVID-19 Drug Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Oral COVID-19 Drug Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Oral COVID-19 Drug Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Oral COVID-19 Drug Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Oral COVID-19 Drug Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oral COVID-19 Drug Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Oral COVID-19 Drug Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Oral COVID-19 Drug Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Oral COVID-19 Drug Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oral COVID-19 Drug Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Oral COVID-19 Drug Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Oral COVID-19 Drug Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Oral COVID-19 Drug Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Oral COVID-19 Drug Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Oral COVID-19 Drug Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Oral COVID-19 Drug Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Oral COVID-19 Drug Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Oral COVID-19 Drug Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Oral COVID-19 Drug Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Oral COVID-19 Drug Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Oral COVID-19 Drug Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Oral COVID-19 Drug Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Oral COVID-19 Drug Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Oral COVID-19 Drug Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Oral COVID-19 Drug Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Oral COVID-19 Drug Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Oral COVID-19 Drug Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oral COVID-19 Drug Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Oral COVID-19 Drug Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Oral COVID-19 Drug Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Oral COVID-19 Drug Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oral COVID-19 Drug Revenue by Country (2023-2028) & (US$ Million)
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Pfizer Oral COVID-19 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Pfizer Recent Developments
Table 110. MSD and Ridgeback Corporation Information
Table 111. MSD and Ridgeback Description and Major Businesses
Table 112. MSD and Ridgeback Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. MSD and Ridgeback Oral COVID-19 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. MSD and Ridgeback Recent Developments
Table 115. Shionogi Corporation Information
Table 116. Shionogi Description and Major Businesses
Table 117. Shionogi Oral COVID-19 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Shionogi Oral COVID-19 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Shionogi Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Oral COVID-19 Drug Distributors List
Table 123. Oral COVID-19 Drug Customers List
Table 124. Oral COVID-19 Drug Market Trends
Table 125. Oral COVID-19 Drug Market Drivers
Table 126. Oral COVID-19 Drug Market Challenges
Table 127. Oral COVID-19 Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral COVID-19 Drug Product Picture
Figure 3. Global Oral COVID-19 Drug Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Oral COVID-19 Drug Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinics
Figure 8. Oral COVID-19 Drug Report Years Considered
Figure 9. Global Oral COVID-19 Drug Sales 2017-2028 (K Units)
Figure 10. Global Oral COVID-19 Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Oral COVID-19 Drug Revenue 2017-2028 (US$ Million)
Figure 12. Global Oral COVID-19 Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Oral COVID-19 Drug Sales Market Share by Region (2017-2022)
Figure 14. Global Oral COVID-19 Drug Sales Market Share by Region (2023-2028)
Figure 15. North America Oral COVID-19 Drug Sales YoY (2017-2028) & (K Units)
Figure 16. North America Oral COVID-19 Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Oral COVID-19 Drug Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Oral COVID-19 Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Oral COVID-19 Drug Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Oral COVID-19 Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Oral COVID-19 Drug Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Oral COVID-19 Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Oral COVID-19 Drug Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Oral COVID-19 Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Oral COVID-19 Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Oral COVID-19 Drug in the World: Market Share by Oral COVID-19 Drug Revenue in 2021
Figure 27. Global Oral COVID-19 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Oral COVID-19 Drug Sales Market Share by Type (2017-2028)
Figure 29. Global Oral COVID-19 Drug Revenue Market Share by Type (2017-2028)
Figure 30. Global Oral COVID-19 Drug Sales Market Share by Application (2017-2028)
Figure 31. Global Oral COVID-19 Drug Revenue Market Share by Application (2017-2028)
Figure 32. North America Oral COVID-19 Drug Sales Market Share by Type (2017-2028)
Figure 33. North America Oral COVID-19 Drug Revenue Market Share by Type (2017-2028)
Figure 34. North America Oral COVID-19 Drug Sales Market Share by Application (2017-2028)
Figure 35. North America Oral COVID-19 Drug Revenue Market Share by Application (2017-2028)
Figure 36. North America Oral COVID-19 Drug Sales Share by Country (2017-2028)
Figure 37. North America Oral COVID-19 Drug Revenue Share by Country (2017-2028)
Figure 38. United States Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Oral COVID-19 Drug Sales Market Share by Type (2017-2028)
Figure 41. Europe Oral COVID-19 Drug Revenue Market Share by Type (2017-2028)
Figure 42. Europe Oral COVID-19 Drug Sales Market Share by Application (2017-2028)
Figure 43. Europe Oral COVID-19 Drug Revenue Market Share by Application (2017-2028)
Figure 44. Europe Oral COVID-19 Drug Sales Share by Country (2017-2028)
Figure 45. Europe Oral COVID-19 Drug Revenue Share by Country (2017-2028)
Figure 46. Germany Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 47. France Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Oral COVID-19 Drug Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Oral COVID-19 Drug Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Oral COVID-19 Drug Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Oral COVID-19 Drug Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Oral COVID-19 Drug Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Oral COVID-19 Drug Revenue Share by Region (2017-2028)
Figure 57. China Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 60. India Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Oral COVID-19 Drug Sales Market Share by Type (2017-2028)
Figure 67. Latin America Oral COVID-19 Drug Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Oral COVID-19 Drug Sales Market Share by Application (2017-2028)
Figure 69. Latin America Oral COVID-19 Drug Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Oral COVID-19 Drug Sales Share by Country (2017-2028)
Figure 71. Latin America Oral COVID-19 Drug Revenue Share by Country (2017-2028)
Figure 72. Mexico Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Oral COVID-19 Drug Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Oral COVID-19 Drug Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Oral COVID-19 Drug Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Oral COVID-19 Drug Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Oral COVID-19 Drug Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Oral COVID-19 Drug Revenue Share by Country (2017-2028)
Figure 81. Turkey Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Oral COVID-19 Drug Revenue (2017-2028) & (US$ Million)
Figure 84. Oral COVID-19 Drug Value Chain
Figure 85. Oral COVID-19 Drug Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

以下、関連資料のご紹介

経口薄膜医薬品製造のグローバル市場インサイト・予測（～2028年）

Global Oral Thin Film Drug Manufacturing Market Insights, Forecast to 2028
QY2207E10448 2022年7月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の経口薄膜医薬品製造の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口薄膜医薬品製造...

世界の薬物詰め経口薄膜市場予測（～2028年）：抗潰瘍薬、鎮咳薬、非ステロイド性抗炎症薬、その他

Global Drug-Loaded Oral Thin Films Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8794 2022年5月 108Pages
薬物詰め経口薄膜市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。<...

薄膜ドラッグデリバリー技術のグローバル市場インサイト・予測（～2028年）

Global Thin-film Drug Delivery Technology Market Insights, Forecast to 2028
QY2207E10500 2022年7月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の薄膜ドラッグデリバリー技術の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に薄膜ドラッ...

経口抗ウイルス薬のグローバル市場インサイト・予測（～2028年）

Global Oral Antiviral Medicine Market Insights, Forecast to 2028
QY2207E10437 2022年7月 93Pages
新型コロナウイルス感染症のパンデミックにより、世界の経口抗ウイルス薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口抗ウイルス薬の世...

グルコン酸カルシウム経口液剤のグローバル市場インサイト・予測（～2028年）

Global Calcium Gluconate Oral Liquid Market Insights, Forecast to 2028
QY2207C3846 2022年7月11日 88Pages
新型コロナウイルス感染症のパンデミックにより、世界のグルコン酸カルシウム経口液剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグルコン...

経口薄膜医薬品製造のグローバル市場インサイト・予測（～2028年） Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via …
世界の薬物詰め経口薄膜市場予測（～2028年）：抗潰瘍薬、鎮咳薬、非ステロイド性抗炎症薬、その他 The Drug-Loaded Oral Thin Films market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
経口抗ウイルス薬のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Oral Antiviral Medicine Market Due to the COVID-19 pandemic, the global Oral Antiviral Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2…
フィナステリド経口錠剤のグローバル市場インサイト・予測（～2028年） Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB). Market Analysis and Insights: Global Finasteride Oral Tablet Market Due to the COVID-19 pandemic, the global Finasteride Oral Tablet market size is estimated to be wo…
世界の経口用グルコン酸カルシウム市場予測（～2028年）：経口液剤、錠剤、顆粒、その他 The Oral Grade Calcium Gluconate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…